NEWS

Updates

Juno & Omega CPHI Conference 2023

By Faris Zeineldin • 10 Oct, 2023
Juno & Omega - CPHI 2023

Juno & Omega - NPAC Conference 2023

By Faris Zeineldin • 26 May, 2023
Juno & Omega - NPAC 2023

Omega Laboratories est fier d'être partenaire avec Juno Pharmaceuticals

By Faris Zeineldin • 15 May, 2023
Juno Pharmaceuticals est fier d'être partenaire avec Omega Laboratories

Juno Pharmaceuticals is proud to acquire Omega Laboratories

By Faris Zeineldin • 15 May, 2023
Juno Pharmaceuticals is proud to acquire Omega Laboratories

Juno Pharmaceuticals approved to import Ketamine, providing immediate relief for hospitals across Canada

By Faris Zeineldin • 05 May, 2023
Juno Pharmaceuticals imports vital medicine as nationwide shortage jeopardizes patient care and comfort

Joint Partnership Announcement

By Faris Zeineldin • 24 Apr, 2023
Juno Pharmaceuticals Canada & Rosemont Joint Partnership Announcement

New Product Launch

By Faris Zeineldin • 06 Apr, 2023
New Product Launch: Bortezomib

Joint Partnership Announcement

By Faris Zeineldin • 06 Apr, 2023
Juno Pharmaceuticals Canada & J. Molner Joint Partnership Announcement

Noromby & Noromby HP New Switching Strategy

By Faris Zeineldin • 30 Mar, 2023
Expanded Biosimilar Drug Programs in Saskatchewan, Newfoundland, and Labrador

Approval from Health Canada to import Eptifibatide solution for infusion and injection

By Faris Zeineldin • 28 Mar, 2023
Approval from Health Canada to import Eptifibatide
Share by: